Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline
- PMID: 16940456
- DOI: 10.1210/jc.2006-0178
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline
Abstract
Objective: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research.
Participants: Participants included expert investigators in the field.
Evidence: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS.
Consensus process: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the AES Board of Directors. No section was finalized until all members were satisfied with the contents and minority opinions noted. Statements that were not supported by peer-reviewed evidence were not included.
Conclusions: Based on the available data, it is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference. A principal conclusion was that PCOS should be first considered a disorder of androgen excess or hyperandrogenism, although a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism but recognized that more data are required before validating this supposition. Finally, the task force recognized, and fully expects, that the definition of this syndrome will evolve over time to incorporate new research findings.
Similar articles
-
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.Fertil Steril. 2009 Feb;91(2):456-88. doi: 10.1016/j.fertnstert.2008.06.035. Epub 2008 Oct 23. Fertil Steril. 2009. PMID: 18950759 Review.
-
Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.Hum Reprod. 2019 Nov 1;34(11):2254-2265. doi: 10.1093/humrep/dez185. Hum Reprod. 2019. PMID: 31751476
-
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17. J Clin Endocrinol Metab. 2006. PMID: 16418211
-
How polycystic ovary syndrome came into its own.F S Sci. 2021 Feb;2(1):2-10. doi: 10.1016/j.xfss.2020.12.007. Epub 2021 Jan 7. F S Sci. 2021. PMID: 35559761 Review.
-
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12. Hum Reprod. 2010. PMID: 19910321
Cited by
-
Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review.Cureus. 2024 Apr 22;16(4):e58733. doi: 10.7759/cureus.58733. eCollection 2024 Apr. Cureus. 2024. PMID: 38779261 Free PMC article. Review.
-
Role of nuclear factor erythroid 2-related factor 2 (Nrf2) in female and male fertility.Heliyon. 2024 Apr 16;10(9):e29752. doi: 10.1016/j.heliyon.2024.e29752. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720768 Free PMC article. Review.
-
Assessment of the Effect of Leonurine Hydrochloride in a Mouse Model of PCOS by Gene Expression Profiling.Genes (Basel). 2024 Apr 18;15(4):507. doi: 10.3390/genes15040507. Genes (Basel). 2024. PMID: 38674441 Free PMC article.
-
Impact of dehydroepiandrosterone sulfate and free androgen index on pregnancy and neonatal outcomes in PCOS patients.Reprod Biol Endocrinol. 2024 Apr 16;22(1):43. doi: 10.1186/s12958-024-01212-y. Reprod Biol Endocrinol. 2024. PMID: 38627777 Free PMC article.
-
Gut bacteriome and mood disorders in women with PCOS.Hum Reprod. 2024 Jun 3;39(6):1291-1302. doi: 10.1093/humrep/deae073. Hum Reprod. 2024. PMID: 38614956 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical